Peptide Based Cancer Therapeutics Market Size Worth $17.18 Billion By 2027 | CAGR: 9.1% |
                     Peptide Based Cancer Therapeutics 
Market
Set to Exceed $17.18 Billion by 2026 | CAGR 9.1%
Peptide Based Cancer Therapeutics Market Share, Size, Trends, 
Industry Analysis Report, By Drug Type (Goserelin, Bortezomib, 
Leuprorelin, and Others); By Cancer Type (Lung, Breast, 
Colorectal, Prostrate, Skin, and Stomach Cancer); By Mode of 
Mechanism (Inhibitory, Necrosis Inducing, and Pro-Apoptotic 
Peptides), By Distribution Channel (Hospital, Retail, and Online 
Pharmacies), By Regions; Segment Forecast, 2020 –2027
Peptide Based Cancer Therapeutics Market Size Worth $17.18 Billion By 2027 | CAGR: 9.1% 
The global peptide based cancer therapeutics market size is expected to reach USD 17.18 
billion by 2027 according to a new study by Polaris Market Research. The report “Peptide 
Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug 
Type (Goserelin, Bortezomib, Leuprorelin, and Others); By Cancer Type (Lung, Breast, 
Colorectal, Prostrate, Skin, and Stomach Cancer); By Mode of Mechanism (Inhibitory, 
Necrosis Inducing, and Pro-Apoptotic Peptides), By Distribution Channel (Hospital, Retail, and 
Online Pharmacies), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight 
into current market dynamics and provides analysis on future market growth.
 
Peptides are compounds that are created by natural or artificial biological linking of amino 
acid monomers. Peptides are being widely used in therapeutics to treat several ailments, 
including cancer owing to their precision based nature, targeting solid tumor cells in the 
body. Peptide based cancer therapeutics have shown effective results against cancer as 
opposed to conventional cancer treatments, without much side effects.
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 2
Peptide Based Cancer Therapeutics Market
By Drug Type By Cancer Type By Mode of Mechanism By Distributing Channel By Region
 Goserelin  Lung  Inhibitory  Hospital  North America (U.S., 
 Bortezomib  Breast  Necrosis Inducing  Retail Canada)
 Leuprorelin  Colorectal  Pro-Apoptotic Peptides  Online Pharmacies  Europe (France, Germany, 
 Others  Prostrate UK, Italy, Spain, 
 Skin Netherlands, Austria)
 Stomach  Asia Pacific (Japan, China, 
India, Malaysia, Indonesia. 
South Korea)
 Latin America (Brazil, 
Mexico, Argentina)
 MEA (Saudi Arabia, UAE, 
Israel, South Africa)
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 3
Peptide Based Cancer Therapeutics Market Estimate & Forecast to 2026
The factors propelling the market growth are the increasing prevalence of cancer across the 
world, cancer screening programs in emerging countries, and the high specificity of peptide 
based cancer vaccines. In 2016, according to analysis by NCA (National Cancer Center), 
1,010,200 cancer cases were recorded, with 576,100 male patients and 434,100 women 
cases. The mortality rate in 2016 recorded a high with more than 374,000 cancer deaths in 
the country, particularly deaths associated with the most common colorectal cancer 
followed by gastric, lung, prostrate and breast cancers.
Access Research Report On Peptide Based Cancer Therapeutics Market Size
Market participants such as AstraZeneca PLC, Abbott, Allergan plc, Teva Pharmaceuticals, 
Pfizer Inc., Takeda Pharmaceutical, Amgen, Inc., Johnson & Johnson, AbbVie Inc., and Valeant 
Pharmaceuticals Inc., are some of the key players operating in the concerned market. In 
January 2020, Sony Brook University (SBU) extended its funding on FABP5 inhibitors to 2025 
by demonstrating novel approach to treat last stage prostate cancer. According to the 
researchers of the SBU specific fatty acid binding protein (FABP) may be help in stopping 
cancer.
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 4
Peptide Based Cancer Therapeutics Market
Request for Sample
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 5
Peptide Based Cancer Therapeutics Market Study – Engagement Options
Buy Now – Click Here!
Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here!
Regional analysis
Segmentation analysis
 Industry outlook
Competitive landscape
Speak To Analyst – Click Here!
Get your doubts clear
Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here!
Get free sample pages 
Understand report structure
Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 6
About Us
Polaris Market Research is a global market research and consulting company. The company 
specializes in providing exceptional market intelligence and in-depth business research services 
for our clientele spread across different enterprises. We at Polaris are obliged to e present across 
the industries of healthcare, technology, semi-conductors and chemicals among various other 
industries present around the world. 
We strive to provide our customers with updated information on innovative technologies, high 
growth markets, emerging business environments and latest business-centric applications, 
thereby helping them always to make informed decisions and leverage new opportunities. Adept 
with a highly competent, experienced and extremely qualified team of experts comprising SMEs, 
analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our 
customers.
 
Web: www.polarismarketresearch.com
Official Blog: https://cmfe-market-research-report.blogspot.com/
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 7
Thank You!
Contact Us :
Polaris Market Research
30 Wall Street
8th Floor, 
New York City, NY 10005,
United States
E mail Id: [email protected]
Phone: +1-646-568-9980